Inspira Technologies Oxy B.H.N. Ltd., a specialty medical device company, engages in the research, development, manufacture, and marketing of respiratory support technology to provide an alternative to invasive mechanical ventilation (MV) for the treatment of respiratory failure. Its lead product is the augmented respiration technology system (ART), a respiratory support system comprising minimally invasive, portable dual lumen cannula, which is inserted into the jugular vein and utilizes extra-corporeal direct blood oxygenation to elevate and stabilize declining oxygen saturation levels. The company was formerly known as Insense Medical Ltd. and changed its name to Inspira Technologies Oxy B.H.N. Ltd. in July 2020. The company was incorporated in 2018 and is based in Ra'annana, Israel.
Earnings for Inspira Technologies Oxy B.H.N. Ltd. (IINN)
Earnings in 2023 (TTM): $-11,286,000
According to Inspira Technologies Oxy B.H.N. Ltd.'s latest financial reports the company's current earnings (TTM) are $-11,286,000. The earnings displayed on this page is the company's Pretax Income.
Earnings history of Inspira Technologies Oxy B.H.N. Ltd.
Annual Earnings
| Year | Income Before Tax | Net Income |
|---|---|---|
| 2023 | $-11,286,000 | $-11,286,000 |
| 2022 | $-10,273,000 | $-4,002,000 |
| 2021 | $-16,955,000 | $-16,961,000 |
| 2020 | $-7,228,000 | $-7,233,000 |
| 2019 | $-4,575,000 | $-4,584,000 |
| 2018 | $-39,600 | $-39,600 |